Catalent, Inc. (CTLT)
After hours:
| Previous Close | 56.00 |
| Open | 56.31 |
| Bid | 0.00 x 800 |
| Ask | 59.99 x 3100 |
| Day's Range | 56.03 - 56.55 |
| 52 Week Range | 31.45 - 60.20 |
| Volume | |
| Avg. Volume | 2,759,240 |
| Market Cap | 10.196B |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
How Novo-Catalent Deal Affects Halozyme (HALO)?
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you […]
- Insider Monkey
Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you […]
- Barrons.com
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
